logo

For the Inventor, By the Inventor

Frankfurt-am-Main, Germany

Eugen Falk

USPTO Granted Patents = 31 

 

Average Co-Inventor Count = 6.0

ph-index = 8

Forward Citations = 254(Granted Patents)


Location History:

  • Franfurt, DE (2002)
  • Frankfurt-am-Main, DE (2000 - 2015)

Company Filing History:

goldMedal13 out of 1,829 
 
Sanofi-a Ventis Deutschland Gmbh
 patents
silverMedal10 out of 330 
 
Aventis Pharma Deutschland, Gmbh
 patents
bronzeMedal5 out of 389 
 
Sanofi-aventis
 patents
4. 2 out of 6,662 
 
Hoechst Aktiengesellschaft
 patents
5. 1 out of 1,454 
 
Sanofi
 patents

Years Active: 2000-2015

Loading Chart...
Loading Chart...
31 patents (USPTO):Explore Patents
1. 8946212 - Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals (2015-02-03),
2. 8329725 - Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals (2012-12-11),
3. 8173674 - Sulfonyl-phenyl-2H-[1,2,4]oxadiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals (2012-05-08),
4. 8048901 - 1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals (2011-11-01),
5. 7956077 - 2-{-3,'2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives used as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes (2011-06-07),
6. 7910612 - 4-oxy-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for their therapeutic use (2011-03-22),
7. 7872034 - Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals (2011-01-18),
8. 7858647 - N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions thereof and methods for their therapeutic use (2010-12-28),
9. 7732471 - 6-oxazol-4-ylmetholmethoxy-alko-alkoxymethyl substituted benzoic acid derivatives forming peroxisome proliferator—activated receptor (PPAR) ligands, process for their preparation and methods of use thereof (2010-06-08),
10. 7601863 - Use of PPAR agonists for the treatment of congestive heart failure (2009-10-13),
11. 7598281 - Arylcycloakyl-substituted alkanoic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes (2009-10-06),
12. 7538131 - 2-{-3-'2-(phenyl)-oxazol-4-ylmethoxymethyl-cyclohexylmethoxy}-propionic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes (2009-05-26),
13. 7399777 - Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmceuticals (2008-07-15),
14. 7365084 - Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals (2008-04-29),
15. 7335671 - Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals (2008-02-26),

Title: Inventor Eugen Falk: Pioneering Innovations in Frankfurt-am-Main

Introduction: Eugen Falk is a distinguished inventor based in Frankfurt-am-Main, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Eugen Falk holds several patents in the areas of renewable energy, sustainable transportation, and advanced materials, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Eugen Falk has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Eugen Falk has collaborated with top engineers, scientists, and inventors, fostering a culture of innovation and excellence in all his projects.

Conclusion: Eugen Falk's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…